Diabetes

News

Boehringer backs NHS trust programme for diabetics

An alliance between German pharma group Boehringer Ingelheim and an NHS trust in the UK has been launched with the aim of reducing recurring heart attacks in people with d

News

FDA panel votes against Intarcia’s GLP-1 implant

Intarcia Therapeutics’ take on the massively successful GLP-1 agonist class of diabetes drugs has failed to convince an FDA advisory committee, which voted unanimously aga

News

NICE changes its mind on Lilly's Mounjaro for diabetes

Around 180,000 people with type 2 diabetes in the UK could be in line for treatment with Eli Lilly's Mounjaro after the drug was recommended for NHS use by cost-effectiven

News

Novo Nordisk buys another obesity biotech

Novo Nordisk has agreed its second acquisition in the space of a month of a biotech in the obesity category, snapping up fellow Danish company Embark Biotech for €15 milli

News

Amazon Pharmacy rolls out insulin discount coupons

Amazon Pharmacy has said that it will automatically apply manufacturer coupons on over 15 insulin and diabetes care products from manufacturers like Novo Nordisk, Eli Lill

News

Embattled Better gets FDA okay for lead DTx product

Digital health company Better Therapeutics has the FDA approval for lead digital therapeutic (DTx) AspyreRx for type 2 diabetes it was hoping for – but now it has to conve

Boehringer backs NHS trust programme for diabetics

FDA panel votes against Intarcia’s GLP-1 implant

NICE changes its mind on Lilly's Mounjaro for diabetes

Novo Nordisk buys another obesity biotech

Amazon Pharmacy rolls out insulin discount coupons

Embattled Better gets FDA okay for lead DTx product

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Diabetes

Editor's Picks